US Tech Solutions · 1 week ago
Biologist III-Cell Line Development
US Tech Solutions is a global staff augmentation firm providing a wide range of talent on-demand. They are seeking a Biologist III for Cell Line Development, responsible for executing experiments and extensive cell culture work while collaborating with various teams.
Information Technology
Responsibilities
Execute experiments in cell line development and characterization with supervision
Extensive cell culture work – both directly and through coordination with the automation sub-team
Perform data acquisition and analysis in a timely manner
Assist in experimental designs, data interpretation and troubleshooting
Document work appropriately in lab notebooks, reports and presentations
Assist with lab operations and continuous improvement activities
Qualification
Required
Must have completed bachelor's degree in Biosciences or related field
Extensive experience with aseptic technique and mammalian cell culture
Microsoft software: Word, Excel, PowerPoint, Outlook
Proven track record of teamwork, adaptability, initiative, and integrity
Excellent interpersonal and both written & oral communication in English
Preferred
Experience with Flow Cytometry (e.g., analysis, compensation, sorting)
Experience with Molecular Biology (e.g., recombinant DNA, vector construction, PCR, NGS)
Experience with Electronic Lab Notebook system (ELN)
Company
US Tech Solutions
US Tech Solutions counted among the largest yet the fastest growing staffing firm; all achieved organically.
H1B Sponsorship
US Tech Solutions has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (4)
2024 (9)
2023 (13)
2022 (24)
2021 (18)
2020 (14)
Funding
Current Stage
Late StageRecent News
Kelly Services, Inc.
2025-05-17
GlobeNewswire News Room
2024-12-13
Company data provided by crunchbase